Halozyme Therapeutics (HALO) Stock Chart & Stock Price History → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free HALO Stock Alerts $51.16 +0.31 (+0.61%) (As of 05:12 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Halozyme Therapeutics Stock Price Performance5 Day Performance+12.68%1 Month Performance+19.21%3 Month Performance+23.27%6 Month Performance+28.76%Year-To-Date Performance+39.18%1 Year Performance+51.47% Receive HALO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Halozyme Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Smallcaps DailyIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution HALO Stock Chart for Monday, June, 10, 2024 HALO Chart by TradingView Halozyme Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$51.44$50.85-1.15%$51.98$50.391.85 million shs$6.47 billion06/06/2024$45.65$51.44+12.68%$52.74$47.334.60 million shs$6.55 billion06/05/2024$44.30$45.65+3.05%$45.78$44.38949,200 shs$5.81 billion06/04/2024$45.05$44.30-1.66%$45.43$44.19675,303 shs$5.64 billion06/03/2024$44.29$45.05+1.72%$45.46$43.641.08 million shs$5.73 billion05/31/2024$43.35$44.29+2.17%$44.52$43.401.18 million shs$5.64 billion Get the Latest News and Ratings for HALO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Halozyme Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$42.76$43.35+1.38%$43.48$42.62867,594 shs$5.52 billion05/29/2024$43.08$42.76-0.74%$42.97$42.051.10 million shs$5.44 billion05/28/2024$43.82$43.08-1.69%$43.97$42.691.03 million shs$5.48 billion05/27/2024$43.82$43.82$44.02$42.96898,700 shs$5.58 billion05/24/2024$43.92$43.82-0.23%$44.02$42.96898,705 shs$5.58 billion05/23/2024$45.48$43.92-3.43%$45.48$43.751.17 million shs$5.59 billion05/22/2024$45.54$45.48-0.13%$45.88$45.08843,307 shs$5.79 billion05/21/2024$44.97$45.54+1.27%$45.57$44.72914,946 shs$5.80 billion05/20/2024$44.71$44.97+0.58%$45.07$44.30656,825 shs$5.72 billion05/17/2024$45.39$44.71-1.50%$45.76$44.351.10 million shs$5.69 billion05/16/2024$45.82$45.39-0.94%$46.16$45.221.04 million shs$5.78 billion05/15/2024$43.82$45.82+4.56%$46.05$44.011.26 million shs$5.83 billion05/14/2024$43.61$43.82+0.48%$45.18$43.551.09 million shs$5.58 billion05/13/2024$43.15$43.61+1.07%$44.00$43.36908,619 shs$5.49 billion05/10/2024$43.84$43.15-1.57%$44.21$43.121.03 million shs$5.48 billion05/09/2024$42.01$43.84+4.36%$43.92$41.301.44 million shs$5.57 billion05/08/2024$41.21$42.01+1.94%$44.79$41.432.12 million shs$5.34 billion05/07/2024$40.86$41.21+0.86%$41.65$40.871.28 million shs$5.24 billion05/06/2024$39.91$40.86+2.38%$40.97$40.23981,063 shs$5.19 billion05/03/2024$39.82$39.91+0.23%$40.74$39.79902,786 shs$5.07 billion05/02/2024$39.30$39.82+1.32%$40.41$38.88832,175 shs$5.06 billion05/01/2024$38.10$39.30+3.15%$40.00$38.291.03 million shs$4.99 billion04/30/2024$38.77$38.10-1.73%$39.03$37.97922,290 shs$4.84 billion04/29/2024$38.57$38.77+0.52%$39.38$38.56728,580 shs$4.93 billion04/26/2024$38.46$38.57+0.29%$39.02$38.46547,082 shs$4.90 billion04/25/2024$39.12$38.46-1.69%$38.75$38.23693,348 shs$4.89 billion04/24/2024$38.97$39.12+0.38%$39.69$38.89620,516 shs$4.97 billion04/23/2024$38.71$38.97+0.67%$39.42$38.75557,947 shs$4.95 billion04/22/2024$38.64$38.71+0.18%$39.04$38.28525,232 shs$4.92 billion04/19/2024$37.81$38.64+2.20%$38.69$37.731.26 million shs$4.91 billion04/18/2024$38.02$37.81-0.55%$38.41$37.73792,530 shs$4.80 billion04/17/2024$38.38$38.02-0.94%$38.78$37.98733,857 shs$4.83 billion04/16/2024$38.72$38.38-0.88%$38.81$38.10642,294 shs$4.88 billion04/15/2024$38.61$38.72+0.28%$39.27$38.48843,653 shs$4.92 billionIt's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution04/12/2024$39.32$38.61-1.81%$39.28$38.53780,317 shs$4.91 billion04/11/2024$39.28$39.32+0.10%$39.78$39.16733,619 shs$5.00 billion04/10/2024$40.13$39.28-2.12%$39.83$38.901.88 million shs$4.99 billion04/09/2024$39.91$40.13+0.55%$40.71$39.52719,098 shs$5.10 billion04/08/2024$41.07$39.91-2.82%$41.36$39.851.16 million shs$5.07 billion04/05/2024$39.73$41.07+3.37%$41.50$39.801.33 million shs$5.22 billion04/04/2024$40.23$39.73-1.24%$40.59$39.441.04 million shs$5.05 billion04/03/2024$40.43$40.23-0.49%$40.67$39.99679,659 shs$5.11 billion04/02/2024$41.32$40.43-2.15%$40.81$39.70943,225 shs$5.14 billion04/01/2024$40.68$41.32+1.57%$41.60$40.38801,003 shs$5.25 billion03/29/2024$40.68$40.68$40.99$40.44707,395 shs$5.17 billion03/28/2024$40.73$40.68-0.12%$40.96$40.45707,132 shs$5.17 billion03/27/2024$40.08$40.73+1.62%$40.94$40.33601,140 shs$5.17 billion03/26/2024$40.42$40.08-0.84%$40.57$39.94625,814 shs$5.09 billion03/25/2024$40.08$40.42+0.85%$40.61$39.90672,983 shs$5.14 billion03/22/2024$40.22$40.08-0.35%$41.03$40.04794,808 shs$5.09 billion03/21/2024$40.38$40.22-0.40%$42.30$40.12928,092 shs$5.11 billion03/20/2024$40.81$40.38-1.05%$40.58$39.69837,234 shs$5.13 billion03/19/2024$40.37$40.81+1.09%$41.33$40.46847,975 shs$5.18 billion03/18/2024$40.86$40.37-1.20%$40.96$40.321.05 million shs$5.13 billion03/15/2024$40.79$40.86+0.17%$41.43$40.561.83 million shs$5.19 billion03/14/2024$41.35$40.79-1.35%$41.31$39.941.50 million shs$5.18 billion03/13/2024$41.95$41.35-1.43%$42.64$41.151.18 million shs$5.25 billion03/12/2024$41.20$41.95+1.82%$42.11$41.28964,210 shs$5.33 billion03/11/2024$41.73$41.20-1.27%$42.25$40.96864,505 shs$5.23 billion Related Companies: TWST Stock Chart IOVA Stock Chart RLAY Stock Chart ADPT Stock Chart FATE Stock Chart ALLO Stock Chart KOD Stock Chart ALNY Stock Chart BMRN Stock Chart NBIX Stock Chart Receive HALO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Halozyme Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:HALO) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Halozyme Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Halozyme Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.